STOCK TITAN

Director Diane Gulyas (NGVT) receives 1,904 Ingevity restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Gulyas Diane H. reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp director Diane H. Gulyas received 1,904 shares of common stock as a grant of restricted stock units. The award was granted at a price of $0.00 per share under Ingevity Corporation's 2025 Omnibus Incentive Plan and will vest in full on April 30, 2027.

Following this grant, she holds 14,788 shares of Ingevity common stock directly. Separately, 3,747 shares are held indirectly through the Diane H. Gulyas Trust, where she serves as trustee and her spouse is the beneficiary.

Positive

  • None.

Negative

  • None.
Insider Gulyas Diane H.
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,904 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 14,788 shares (Direct, null); Common Stock — 3,747 shares (Indirect, By trust)
Footnotes (1)
  1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027. Held through the Diane H. Gulyas Trust, of which the reporting person is trustee and the reporting person's spouse is beneficiary.
RSU grant 1,904 shares Restricted stock units granted April 30, 2026
Grant price $0.00 per share Equity award under 2025 Omnibus Incentive Plan
RSU vesting date April 30, 2027 Full vesting date for 1,904 RSUs
Direct holdings after grant 14,788 shares Common stock held directly after transactions
Indirect holdings via trust 3,747 shares Common stock held through Diane H. Gulyas Trust
restricted stock units financial
"Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Omnibus Incentive Plan financial
"pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full"
An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.
trustee financial
"Held through the Diane H. Gulyas Trust, of which the reporting person is trustee"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
beneficiary financial
"the Diane H. Gulyas Trust, of which the reporting person's spouse is beneficiary"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gulyas Diane H.

(Last)(First)(Middle)
4920 O'HEAR AVE
SUITE 400

(Street)
NORTH CHARLESTON SOUTH CAROLINA 29405

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/30/2026A1,904(1)A$014,788D
Common Stock3,747IBy trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.
2. Held through the Diane H. Gulyas Trust, of which the reporting person is trustee and the reporting person's spouse is beneficiary.
Remarks:
Diane H. Gulyas By: Mavis G. Huger as Attorney-in-Fact05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ingevity (NGVT) disclose for Diane H. Gulyas?

Ingevity disclosed that director Diane H. Gulyas received 1,904 shares of common stock as a grant of restricted stock units. The award carries a $0.00 grant price and was made under the company’s 2025 Omnibus Incentive Plan as equity-based compensation.

When do Diane H. Gulyas’s new Ingevity (NGVT) restricted stock units vest?

The 1,904 restricted stock units granted to Diane H. Gulyas will vest in full on April 30, 2027. Once vested, these units convert into shares of common stock, subject to any applicable plan terms or continued service requirements noted in the incentive plan.

How many Ingevity (NGVT) shares does Diane H. Gulyas hold after this Form 4?

After the reported transactions, Diane H. Gulyas holds 14,788 shares of Ingevity common stock directly. In addition, 3,747 shares are held indirectly through the Diane H. Gulyas Trust, giving a combined reported position across direct and indirect ownership categories.

What is the nature of Diane H. Gulyas’s indirect Ingevity (NGVT) holdings?

The filing states that 3,747 Ingevity common shares are held through the Diane H. Gulyas Trust. She is the trustee of this trust, and her spouse is the beneficiary, meaning the indirect holdings are managed via this trust arrangement rather than in her personal name.

Was Diane H. Gulyas’s Ingevity (NGVT) stock grant an open-market purchase?

No, the 1,904-share transaction is coded as an acquisition from a grant or award, not an open-market purchase. It represents a restricted stock unit award at a $0.00 grant price under Ingevity’s 2025 Omnibus Incentive Plan, reflecting equity compensation rather than a market trade.

What plan governs Diane H. Gulyas’s new Ingevity (NGVT) restricted stock units?

The restricted stock units granted to Diane H. Gulyas were issued under Ingevity Corporation’s 2025 Omnibus Incentive Plan. This plan provides the framework for equity-based awards, including vesting terms, grant mechanics, and other conditions applicable to directors and eligible participants.